While additional tumor characteristics such as Ki-67 proliferative index could ideally guide decision making regarding resection [78], at present tumor size has been the most reliable determinant of tumor progression for well-differentiated PNET. This evidence concerns the gene MKI67 and primitive neuroectodermal tumor.